Skip to main content

Table 3 Crude cost estimate reported in dialysis patients (HD + PD)

From: Additional cost of end-stage kidney disease in diabetic patients according to renal replacement therapy modality: a systematic review

Author

Year

comparator

Stratification

Value of non-DM (SD)

Value of DM (SD)

Diff

p

Grun et al. [23]

2003

Mean cost per day (₤)

None

68.5 (30.5)

68.1 (28.1)

−1%

0.94

Su et al. [25]

2010

Dialysis cost (NT)

None

1467.53 (220.9)

1481.6 (209.13)

1%

0.664

Yang et al. [26]

2001

Total cost (US$/patient-year)

None

24,146

26,988

12%

 

Outpatient (US$/patient-year)

None

22,820

22,311

−2%

 

Dialysis and EPO

None

21,209

19,841

−6%

 

Other clinic

None

1611

2470

53%

 

Hospitalization (US$/patient-year)

None

1325

4677

253%

 

Dialysis and EPO

None

409

1093

167%

 

Others

None

916

3584

291%

 

Bruns et al. [28]

1997

Costs per patient-year ($)

All

55,581

68,228

23%

 

20–44

48,927

51,884

6%

 

45–64

65,707

72,643

11%

 

65–74

48,062

77,418

61%

 

≥75

59,594

46,746

−22%

 

Smith et al. [36]

1989

Annual charges HD in centers

None

23,470

27,463

17%

 

Annual charges PERI in centers

None

22,529

26,486

18%

 

Annual charges CAPDTR

None

18,408

17,879

−3%

 

Annual charges CAPDH

None

22,753

29,435

29%

 

Annual charges Other

None

28,342

40,779

44%

 

Weighted average

None

24,976

29,671

19%

 
  1. NT New Taiwan, EPO erythropoietin, PERI in center peritoneal dialysis, CAPDTR continuous ambulatory peritoneal dialysis training, CAPDH combinations of dialysis treatments